Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-01-26 12:21 pm Purchase |
2021-01-22 | 13G | Infinity Pharmaceuticals, Inc. INFIQ |
EcoR1 Capital LLC | 4,368,500 6.800% |
4,368,500 (New Position) |
Filing History |
| 2021-01-22 4:27 pm Purchase |
2021-01-12 | 13G | AC Immune SA ACIU |
EcoR1 Capital LLC | 4,702,160 6.600% |
4,702,160 (New Position) |
Filing History |
| 2021-01-14 4:59 pm Purchase |
2021-01-04 | 13G | AnaptysBio, Inc. ANAB |
EcoR1 Capital LLC | 3,813,324 13.900% |
1,847,224 (+93.95%) |
Filing History |
| 2021-01-04 4:42 pm Purchase |
2020-12-22 | 13G | ARS Pharmaceuticals, Inc. SPRY |
EcoR1 Capital LLC | 2,533,635 7.300% |
2,533,635 (New Position) |
Filing History |
| 2021-01-04 4:30 pm Purchase |
2020-12-28 | 13G | GRITSTONE BIO INC GRTSQ |
EcoR1 Capital LLC | 4,934,932 9.990% |
4,934,932 (New Position) |
Filing History |
| 2020-11-02 4:04 pm Purchase |
2020-10-23 | 13G | Solid Biosciences Inc. SLDB |
EcoR1 Capital LLC | 351,667 9.800% |
351,667 (New Position) |
Filing History |
| 2020-08-28 4:06 pm Purchase |
2020-08-19 | 13G | Sutro Biopharma, Inc. STRO |
EcoR1 Capital LLC | 2,328,492 6.500% |
2,328,492 (New Position) |
Filing History |
| 2020-07-20 4:34 pm Purchase |
2020-07-10 | 13G | GlycoMimetics, Inc. GLYC |
EcoR1 Capital LLC | 2,909,800 6.700% |
2,909,800 (New Position) |
Filing History |
| 2020-06-17 4:42 pm Purchase |
2020-06-08 | 13G | Xencor, Inc. XNCR |
EcoR1 Capital LLC | 4,547,072 8.000% |
4,547,072 (New Position) |
Filing History |
| 2020-05-29 4:13 pm Purchase |
2020-05-19 | 13G | Surface Oncology, Inc. SURF |
EcoR1 Capital LLC | 5,033,861 12.800% |
3,732,148 (+286.71%) |
Filing History |
| 2020-05-29 4:05 pm Purchase |
2020-05-22 | 13G | Geron Corporation GERN |
EcoR1 Capital LLC | 28,846,154 9.100% |
28,846,154 (New Position) |
Filing History |
| 2020-05-01 5:29 pm Purchase |
2020-04-24 | 13G | ORIC Pharmaceuticals, Inc. ORIC |
EcoR1 Capital LLC | 2,642,218 8.800% |
2,642,218 (New Position) |
Filing History |
| 2020-04-24 4:35 pm Purchase |
2020-04-16 | 13G | Merus N.V. MRUS |
EcoR1 Capital LLC | 1,906,861 6.600% |
188,661 (+10.98%) |
Filing History |